Latest Articles

Publication Date
Curcumol alleviates endometriosis via correcting the aberrant activation of Fas/RIPK1-mediated PANoptosis.

Endometriosis (EMs) is an estrogen-dependent chronic inflammatory disease. While apoptosis resistance (evidenced by Bcl-2 upregulation and Bax/caspase-3 downregulation) remains a hallmark of EMs, recent studies reveal a paradoxical coexistence of …

Published: Nov. 18, 2025, midnight
Curcumol alleviates endometriosis via correcting the aberrant activation of Fas/RIPK1-mediated PANoptosis - Frontiers

Curcumol alleviates endometriosis via correcting the aberrant activation of Fas/RIPK1-mediated PANoptosis Frontiers

Published: Oct. 27, 2025, 4:10 p.m.
Multi-Omics Analysis of the Anti-Cancer Effects of Curcumol in Endometrial Carcinoma - Frontiers

Multi-Omics Analysis of the Anti-Cancer Effects of Curcumol in Endometrial Carcinoma Frontiers

Published: June 13, 2025, 5:14 a.m.
Curcumol inhibits endometrial cell invasion through the NF-κB pathway in rats with endometriosis.

Curcumol (Cur) has been found to be useful in improving Endometriosis (EMS), however its mechanism of action is still not completely understood. Based on this, the current study was carried …

Published: Feb. 12, 2025, 12:13 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!